학술논문

Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia March 2024
Subject
Language
ISSN
2152-2650